SCHEMBL13330591

SCHEMBL13330591

CC(F)(F)c1cc(Cl)c2nc(-c3noc(-c4cc(F)c(NS(C)(=O)=O)c(Cl)c4)n3)cn2c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.38
NFKB1 P19838 4/20 0.38
RAB9A P51151 4/20 0.38
NFKB2 Q00653 4/20 0.38
RELA Q04206 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PKM P14618 1/20 0.34
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3345698 0.94 SMN1; SMN2 (0.45) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL3342850 0.87 SMN1; SMN2 (0.45) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL3343850 0.83 SMN1; SMN2 (0.47) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL3338490 0.77 SMN1; SMN2 (0.43) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL3340205 0.76 SMN1; SMN2 (0.49) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL3340718 0.74 NPC1 (0.48) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL3340793 0.73 NPC1 (0.50) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL3341490 0.73 SMN1; SMN2 (0.43) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL3339591 0.72 NPC1 (0.45) NPC1NFKB1RAB9ANFKB2RELA
SCHEMBL3341771 0.72 NPC1 (0.42) NPC1NFKB1RAB9ANFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010065760-A1 IMIDAZO [1,2A] PYRIDINE DERIVATIVES, THEIR USE AS S1P1 AGONISTS AND METHODS FOR THEIR PRODUCTION EXELIXIS, INC. (US) 2010-06-10 WO disclosed